|
CSNK1A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.16680000000902E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.761100E-04 |
| Normal-vs-Stage2 |
2.518100E-02 |
| Normal-vs-Stage3 |
1.858220E-03 |
| Normal-vs-Stage4 |
8.847500E-04 |
| Stage1-vs-Stage2 |
9.484400E-01 |
| Stage1-vs-Stage3 |
8.322600E-01 |
| Stage1-vs-Stage4 |
8.068200E-01 |
| Stage2-vs-Stage3 |
9.408400E-01 |
| Stage2-vs-Stage4 |
9.273200E-01 |
| Stage3-vs-Stage4 |
9.823800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.76060000000233E-05 |
| Normal-vs-AfricanAmerican |
4.949200E-01 |
| Normal-vs-Asian |
2.109000E-01 |
| Caucasian-vs-AfricanAmerican |
1.615520E-03 |
| Caucasian-vs-Asian |
5.994000E-01 |
| AfricanAmerican-vs-Asian |
2.787400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.000800E-04 |
| Normal-vs-Female |
1.567800E-04 |
| Male-vs-Female |
5.443800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.116000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.959590E-04 |
| Normal-vs-Age(61-80Yrs) |
2.848600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.636300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.959200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.418800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.888800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.962200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.634400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.088800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.876300E-02 |
| Normal-vs-Grade 2 |
3.9655999999999E-05 |
| Normal-vs-Grade 3 |
1.357310E-03 |
| Normal-vs-Grade 4 |
5.962200E-03 |
| Grade 1-vs-Grade 2 |
8.070400E-01 |
| Grade 1-vs-Grade 3 |
6.887400E-01 |
| Grade 1-vs-Grade 4 |
8.773600E-01 |
| Grade 2-vs-Grade 3 |
8.527600E-02 |
| Grade 2-vs-Grade 4 |
3.666600E-01 |
| Grade 3-vs-Grade 4 |
6.764200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.05890000001718E-06 |
| Normal-vs-ccB subtype |
4.738300E-03 |
| ccA subtype-vs-ccB subtype |
4.640300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.837560E-04 |
| Normal-vs-N1 |
1.391160E-01 |
| N0-vs-N1 |
7.127800E-01 |
|
|
